ESLAW vs IONS
Estrella Immunopharma Inc. (ESLAW) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
ESLAW does not have a complete income-statement cache yet.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ESLAW currently screens at market cap $0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ESLAW and IONS stock pages for the full models.
Not investment advice.